Hungary claws extra 8% of drug costs back from manufacturers as part of €60mn cuts
This article was originally published in Scrip
Executive Summary
Subject to the approval of the Hungarian parliament, Hungary's government is raising drug manufacturers' rebate on their reimbursed products sales from the current 12% to 20%. It may come into force in July this year, according to Dr Miklos Szocska, the health minister.